sylvain giraud
A Brussels bureaucrat / @EU_Health policy / Effective Accessible Resilient Health Systems / views expressed are my own / RT not endorsement /🌈
Last synced from Twitter 0m ago
Parcours de soins : « Face à la logique hospitalo-centrée, un autre dispositif est possible »
TRIBUNE. Dans une tribune au « Monde », un collectif de directeurs d’établissement de santé appelle médecins généralistes, établissements de santé, mais aussi patients et collectivités locales à la coordination des soins, lors des maladies...
sylvain giraud
Parcours de soins : « Face à la logique hospitalo-centrée, un autre dispositif est possible » — via @lemondefr
8h
Des polluants organiques persistants liés à l’agressivité du cancer du sein
Selon une étude française, trois de ces substances augmenteraient le risque d’une propagation des cellules cancéreuses aux ganglions lymphatiques, particulièrement chez les patientes en surpoids.
sylvain giraud
Des polluants organiques persistants liés à l’agressivité du cancer du sein — via @lemondefr
8h
Accès aux médicaments : l’imbroglio des brevets
Pour faciliter l’accès des pays pauvres à certains traitements essentiels, de nouveaux modèles de développement des molécules et de gestion de la propriété intellectuelle ont vu le jour. Non sans certaines réticences. Enquête.
Big Pharma has failed: the antibiotic pipeline needs to be taken under public ownership
The pipeline for new antibiotics is broken. It is time to think outside the box.
« Meduza », média russe en exil
Ce site d’information, créé par des journalistes russes partis en Lettonie pour préserver leur liberté, continue de traiter dans l’adversité l’actualité du pays de Vladimir Poutine.
"L'Ue si è data una missione, la lotta contro il cancro". Intervista a Walter Ricciardi
Il capo del Mission Board for Cancer all'Huffpost: "Fatti grandi progressi, ma siamo indietro su tumori a pancreas e sistema nervoso". Recente la nomina a Human Technopole: "È opportunità per tutta l'Italia, Elena Cattaneo sbaglia a volerlo frenare"
EU drug approval should include price evaluation, says expert panel
New drugs should not be approved for sale in the European Union (EU) unless pharmaceutical companies agree to a fair price, an expert panel has urged.
Speaking at the European Public Health Alliance’s Universal Access and Affordable Medicines forum...
New EPHA study reveals more needs to be done on AMR National Action Plans in Europe
A new study from EPHA maps the development and implementation of NAPs on AMR or similar initiatives in the 28 EU Member States and Iceland, Norway, and Switzerland
Implications of Overprescription of Antibiotics: A Cross-Sectional Study
The use of antibiotics in recent years has become more aggressive and more common. The inappropriate use, to be more precise, the abuse of these prescriptions, is the root cause for increasing bacterial resistance and adverse outcomes. Antisepsis...
Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions
AbstractAims. Ambient air pollution is a major health risk, leading to respiratory and cardiovascular mortality. A recent Global Exposure Mortality Model, base
New antibiotics won’t stop antimicrobial resistance. Luckily, there are other things we can try
Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet.
1
sylvain giraud
New antibiotics won’t stop antimicrobial resistance. Luckily, there are other things we can try Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. imi.europa.eu/news-events/ne… via @IMI
15h
‘Why can’t I get my medicine?’
File on 4 looks at the impact Britain's medicine shortage crisis is having on patients.
Progress is too slow in the fight against 'superbugs', auditors warn
Despite some progress, the EU One Health approach to antimicrobial resistance (AMR) has not yet delivered demonstrable results in reducing the rising 'superbugs' health threat, the European Court of Auditors (ECA) found.
L'hôpital n'est pas un coût, mais un investissement
L'enveloppe consacrée aux hôpitaux pour 2020 n'est pas à la hauteur des besoins, estime Frédéric Valletoux. Il faut absolument sortir de la seule logique comptable.
Pourquoi l'éthique de l'intelligence artificielle en santé est-elle un faux débat ?
Nombreux sont les discours et les rapports officiels qui débattent sur le cadre éthique qu'il conviendrait d'imposer à l'IA dans le domaine de la santé. Ethique et droit sont alors très souvent confondus. Pourtant, derrière ces considérations...
Cost of drugs prescribed in primary care continues to fall
The cost of drugs prescribed in primary care fell by 2.8% in 2018-19, data from NHS Digital show.1 Over the same period the cost of drugs prescribed in hospitals rose by 11.1%.
Hospitals accounted for 53.7% (£10.2bn (€11.9bn; $13.2bn)) …
The Hidden Power Of Palliative Care
For many patients, palliative care is the best kind of medicine.
sylvain giraud
"we as a whole are directing valuable health care resources toward hospital-based end-of-life care that few people want and that many people say is inadequate (...) Physicians could put less emphasis on trying to cure late-stage illnesses"
21h
Taking Collective Action to Address AMR and Promote the Development of New Antimicrobials (Guest Blog)
Unlike Zika virus or SARS, antimicrobial resistance (AMR) is a predictable phenomenon. We have known since the first antibacterials were introduced that drug resistance inevitably follows. Put simply, when we use them, sooner or later, we lose them....
20 years of EURACTIV: Vestager says without free media there is no democracy
Without free Press then the public space will be muted and voiceless and therefore, there will be no democracy, EU Commissioner Margrethe Vestager said yesterday at an event to celebrate EURACTIV’s 20th anniversary. Also find out about party clashes...
2
sylvain giraud
Vestager: "The point of being digital is to make the most of digital to create the societies that we dream of based on human welfare and freedom."
21h
Le startupisme: Le fantasme de la startup nation
Le startupisme: Le fantasme technologique et économique de la startup nation
sylvain giraud
Le startupisme. Le fantasme technologique et économique de la startup nation - FYP Editions
22h